期刊文献+

舒利迭治疗慢性阻塞性肺疾病临床疗效观察 被引量:5

Observation of the Clinical Therapeutic Effect of Seretide in Treating Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的:观察舒利迭治疗慢性阻塞性肺疾病(COPD)的疗效。方法:我院呼吸科就诊的COPD患者120例,随机分为治疗组和对照组。对照组给予常规治疗,治疗组在此基础上给予吸入舒利迭。结果:治疗组的总有效率显著高于对照组,两组疗效比较差异有显著性意义(P<0.01);治疗组的氧分压(PaO2)治疗后显著高于对照组(P<0.05);二氧化碳分压(PaCO2)则显著低于对照组(P<0.05);治疗组的FEV1、FVC治疗后显著高于对照组(P<0.05)。舒利迭无明显的毒副作用。结论:应用舒利迭治疗COPD在临床上能显著改善动脉血气指标,使用安全,值得在临床上推广。 Objective To investigate the effects of Seretide in the treatment of chronic obstructive pulmonary disease (COPD). Methods Respiratory department for treatment of 120 cases of COPD were randomly divided into treatment group and control group. The control group received conventional,the treatment group was given inhaled seretide on this basis. Results There was a significant difference between the two groups (P<0.01), the overall effective rate in treatment group significantly higher than in control group...
作者 郝春阳
机构地区 鞍山市中心医院
出处 《实用医技杂志》 2007年第17期2279-2280,共2页 Journal of Practical Medical Techniques
关键词 舒利迭 慢性阻塞性肺疾病 疗效 Seretide COPD Curative effect
  • 相关文献

参考文献1

二级参考文献8

  • 1Meltzer EO, Lockey RE, Friedman BF, et al. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma. Mayo Clin Proc,2002,77(5) :437.
  • 2Staresinic AG, Sorkness CA. Fluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma. Expert Opin Pharmacother,2000,1(6) : 1227.
  • 3Barnes NC, Hallett C, Harris TA. Clinical experience with fluticasone propionate in asthma : a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med, 1998,92(1) :95.
  • 4Direkwattanachai C, Limkittikul K, Kraisarin C, et al. Fluticasone propionate and bronchial hyperresponsiveness in childhood asthma.Asian Pac J Allergy Immunol, 1999,17(2) :63.
  • 5Heinig JH, Boulet LP, Croonenborghs L, et al. The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma. Respir Med,1999,93(9) :613.
  • 6Visser MJ, Postma DS, Arends LR, et al. One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma:effects on hyperresponsiveness, lung function, and height.Am J Respir Crit Care Med,2001,164(11):2073.
  • 7Li JT, Ford LB, Chervinsky P, et al. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. J Allergy Clin Immunol, 1999,103(6) : 1062.
  • 8儿童哮喘防治常规(试行)[J].中华儿科杂志,1998,36(12):747-751. 被引量:2372

共引文献21

同被引文献48

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部